“We kept our position as no. 2 on the market of distribution to hospitals, amid a 42% sales increase. (…) The turnover increase was due to strategic partnerships with suppliers and due to the focus on segments with above-market growth,” said Coca Cascaval, general manager of Polisano. She said the turnover increase was also based on the rise of the retail segment (drugstore sales).
Polisano is the largest firm in Vonica’s group. Ilie Vonica, 55, employs around 2,000 people in his group, which also includes a drugstore chain (Reteta), a manufacturing facility (Polipharma Industries), a generalist clinic network (Clinica Polisano), and a private hospital (in Sibiu).
This year, Vonica’s wholesale business could exceed EUR350 million in sales.
Romania’s drug market grew in all crisis years. In 2011, the pharmaceutical market growth was 11.5%.
(English version by Daniela Stoican)